Advertisement

Topics

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results

16:05 EDT 13 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, toda...

Other Sources for this Article

Senseonics Holdings, Inc.
INVESTOR CONTACT
R. Don Elsey
Chief Financial Officer
301.556.1602
don.elsey@senseonics.com

NEXT ARTICLE

More From BioPortfolio on "Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...